Connecticut Innovations (CI) is in line for $25 million via the state Bond Commission to recapitalize its equity investment programs and another $10 million for regenerative medicine research grants for Yale, UConn, and Jackson Labs.

In its investment committee meetings in September and October, CI discussed follow-on investment proposals for a number of companies, including Bioarray Therapeutics in Farmington and CMD Bioscience in New Haven.